Phibro Animal Health Quarterly Income Statement
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Phibro Animal Health revenue and earnings
In the quarter ended Jun 30, 2026, Phibro Animal Health generated $396.7 million in revenue, up 4.8% from the same quarter a year earlier. Net income was $21.7 million (+26.0% year over year), for a net margin of 5.5% versus a median of 6.3% in the prior 5 quarters. Gross margin was 33.9% (up from 29.0%) and operating margin 12.1%.
Diluted earnings per share came in at $0.52, up from $0.43.
Summary generated from market data by MetaCap's automated system. Methodology
Phibro Animal Health income statement (quarterly)
| Quarter (USD) | Q4 20262026-06-30 | Q3 20262026-03-31 | Q2 20262025-12-31 | Q1 20262025-09-30 | Q4 20252025-06-30 | Q3 20252025-03-31 | Q2 20252024-12-31 | Q1 20252024-09-30 | Q4 20242024-06-30 | Q3 20242024-03-31 | Q2 20242023-12-31 | Q1 20242023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 396.75M | 383.54M | 373.91M | 363.89M | 378.70M | 347.82M | 309.26M | 260.43M | 273.16M | 263.22M | 249.94M | 231.35M |
| Revenue growth (YoY) | +4.77% | +10.27% | +20.90% | +39.73% | +38.63% | +32.14% | +23.73% | +12.57% | +7.10% | +7.14% | +2.17% | -0.50% |
| Cost of Revenue | 262.35M | 257.87M | 241.25M | 244.11M | 268.69M | 243.26M | 207.39M | 176.94M | 186.01M | 183.62M | 171.33M | 163.62M |
| Gross Profit | 134.40M | 125.67M | 132.66M | 119.78M | 110.01M | 104.57M | 101.87M | 83.50M | 87.15M | 79.60M | 78.62M | 67.73M |
| Operating Expenses | 86.24M | 81.02M | 82.33M | 68.52M | 76.29M | 71.05M | 76.34M | 65.80M | 68.73M | 59.68M | 62.91M | 68.45M |
| Selling, General & Admin | 86.24M | 81.02M | 82.33M | 68.52M | 76.29M | 71.05M | 76.34M | 65.80M | 68.73M | 59.68M | 62.91M | 68.45M |
| Operating Income | 48.16M | 44.65M | 50.33M | 51.26M | 33.72M | 33.52M | 25.53M | 17.70M | 18.42M | 19.92M | 15.70M | -726.00K |
| Interest Expense | 10.71M | 10.68M | 12.48M | 12.54M | 9.03M | 9.65M | 9.78M | 8.77M | 6.00M | 5.64M | 5.72M | 5.64M |
| Pretax Income | 32.34M | 32.31M | 36.42M | 36.27M | 23.85M | 29.69M | 4.84M | 9.62M | 6.41M | 12.92M | 3.56M | -11.98M |
| Income Tax | 10.63M | 8.29M | 8.97M | 9.74M | 6.62M | 8.81M | 1.65M | 2.65M | 5.66M | 4.52M | 2.29M | -3.96M |
| Net Income | 21.71M | 24.02M | 27.46M | 26.53M | 17.22M | 20.88M | 3.19M | 6.97M | 752.00K | 8.40M | 1.27M | -8.02M |
| Net Income growth (YoY) | +26.05% | +15.06% | +762.14% | +280.32% | +2190.43% | +148.42% | +150.00% | — | -93.46% | -16.30% | -82.33% | -307.86% |
| EPS (Basic) | 0.54 | 0.59 | 0.68 | 0.65 | 0.42 | 0.52 | 0.08 | 0.17 | 0.02 | 0.21 | 0.03 | -0.20 |
| EPS (Diluted) | 0.52 | 0.59 | 0.67 | 0.65 | 0.43 | 0.51 | 0.08 | 0.17 | 0.02 | 0.21 | 0.03 | -0.20 |
| Shares Outstanding (Basic) | — | 40.55M | 40.53M | 40.53M | — | 40.52M | 40.50M | 40.50M | — | 40.50M | 40.50M | 40.50M |
| Shares Outstanding (Diluted) | — | 41.04M | 40.96M | 40.88M | — | 40.71M | 40.72M | 40.58M | — | 40.52M | 40.50M | 40.50M |
| EBITDA | 61.50M | 57.10M | 63.22M | 64.09M | 46.13M | 46.13M | 37.11M | 26.70M | 27.62M | 29.12M | 24.61M | 8.14M |
| Gross Margin | 33.88% | 32.77% | 35.48% | 32.92% | 29.05% | 30.06% | 32.94% | 32.06% | 31.90% | 30.24% | 31.45% | 29.27% |
| Operating Margin | 12.14% | 11.64% | 13.46% | 14.09% | 8.90% | 9.64% | 8.26% | 6.80% | 6.74% | 7.57% | 6.28% | -31.00% |
| Net Margin | 5.47% | 6.26% | 7.34% | 7.29% | 4.55% | 6.00% | 103.00% | 2.68% | 28.00% | 3.19% | 51.00% | -3.46% |
This table shows 12 quarterly periods of Phibro Animal Health's income statement, from Q4 2026 back to Q1 2024, across 19 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow PAHC's reporting calendar. What is a income statement?